PBS Biotech Raises $10M to Provide Scale-Up Manufacturing Solutions for Cell Therapies

CAMARILLO, Calif.--(BUSINESS WIRE)--Single-use bioreactor manufacturer, PBS Biotech, recently closed a private $10M funding round with BroadOak Capital Partners. The financing will enable the company to expand and industrialize its portfolio of single-use bioreactor systems and contract process development services. “Cell therapies represent a paradigm shift that enable durable cures for...

Click to view original post